Cyclooxygenase-2 inhibitors and prostate cancer

Lancet Oncol. 2007 Oct;8(10):859-60. doi: 10.1016/S1470-2045(07)70291-7.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clinical Trials as Topic
  • Cyclooxygenase 2 / physiology
  • Cyclooxygenase 2 Inhibitors / therapeutic use*
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / enzymology
  • Prostatic Neoplasms / radiotherapy

Substances

  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase 2